Megumi Tatsumi
Kodaira, 1878551, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Ethanolamine as a potential biomarker and therapeutic target for depressive disorder.
Journal: Molecular psychiatry
Published: May 02, 2025
Cerebrospinal fluid neuromarker levels in patients with schizophrenia: a multiplex immunoassay study with a large sample.
Journal: Psychiatry and clinical neurosciences
Published: March 22, 2025
Possible association of elevated CSF IL-6 levels with anxiety and frustration in psychiatric disorders.
Journal: Psychiatry and clinical neurosciences
Published: June 12, 2024
Correlation between myelin basic protein levels in cerebrospinal fluid and motor speed in patients with schizophrenia.
Journal: Neuropsychopharmacology reports
Published: April 10, 2024
Association between vascular endothelial growth factor-mediated blood-brain barrier dysfunction and stress-induced depression.
Journal: Molecular psychiatry
Published: August 23, 2021
Distinct and overlapping roles of ARID3A and ARID3B in regulating E2F‑dependent transcription via direct binding to E2F target genes.
Journal: International journal of oncology
Published: October 10, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026